FDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.
6 reports, 1 independent
Updated Nov 10
Gone quiet
- Reports
- 6
- Developments
- 4
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Clearmind is conducting Phase II trials and presented its findings to the FDA.1 source
Clearmind Medicine Inc. held clinical trials at Yale and Johns Hopkins and submitted data to the FDA.1 source
Clearmind Medicine Inc. is undergoing FDA-overseen trials in the US and Israel.1 source
Clearmind Medicine Inc. achieves Nasdaq listing, FDA oversight, and clinical trial partnerships.1 source
Keep exploring
The entities involved
Related events
- The FDA is a U.S. government agency, a basic descriptive fact about the regulator.
- Abivax SA, a French company, is conducting clinical trials in the US and seeking alignment on NDA submission strategy with the FDA.
- An AI-designed drug is currently in trials, prompting a focus on global legal and ethical standards.
- FDA reviewed an NDA and entered a clinical study agreement for a babesiosis trial involving 60 Degrees Pharmaceuticals.
- InflaRx is seeking discussions with the FDA and collaborating with Staidson BioPharmaceuticals on clinical trials.
Coverage
Newest first; wire copies grouped- manilatimes.net
- manilatimes.net
- manilatimes.net
- manilatimes.netClearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
- manilatimes.net
- manilatimes.net